Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Cancer
Gilead, Tubulis to collaborate on ADC program
By
LabPulse.com staff writers
Gilead and biotech firm Tubulis have forged an exclusive option and license agreement to discover and develop an antibody-drug conjugate (ADC) against an undisclosed solid tumor target.
December 3, 2024
Jury awards Guardant nearly $293M in lawsuit against Natera
By
LabPulse.com staff writers
A federal jury in the U.S. District Court for the Northern District of California ruled in favor of Guardant Health in a lawsuit the company filed against Natera in May 2021.
November 26, 2024
Lunit adds AstraZeneca for NSCLC biomarker screening AI
By
LabPulse.com staff writers
Companies to integrate Scope Genotype Predictor into pathology workflows to screen for actionable mutations in non-small cell lung cancer research.
November 18, 2024
Biofidelity launches lung reagent for integrated tissue and liquid biopsy analysis
By
LabPulse.com staff writers
Biofidelity has launched its Aspyre Lung Reagents molecular diagnostic assay for identifying NSCLC biomarkers in both DNA and RNA.
November 14, 2024
Brain tumor collaborative offers $500K for practice changing liquid biopsy studies
By
LabPulse.com staff writers
The research should be practice-changing.
November 14, 2024
Mainz Biomed, Thermo Fisher collaborate on CRC screening test
By
LabPulse.com staff writers
Mainz Biomed and Thermo Fisher Scientific will jointly develop and potentially commercialize Mainz Biomed's next-generation colorectal cancer (CRC) screening test.
November 12, 2024
Inify, Karolinska Institutet partner on AI-driven prostate cancer diagnostics
By
LabPulse.com staff writers
Digital pathology firm Inify Laboratories is collaborating with scientists at the Karolinska Institutet in Stockholm on a project aimed at improving the precision of prostate cancer diagnosis through artificial intelligence (AI)-driven image analysis.
November 5, 2024
CMS Medicare fee schedule includes blood tests for CRC screening
By
LabPulse.com staff writers
In the 2025 Medicare Physician Fee Schedule final rule, the U.S. Centers for Medicare and Medicaid Services (CMS) updated coverage for a complete colorectal cancer (CRC) screening to include Medicare-covered blood-based biomarker CRC screening tests.
November 5, 2024
Abzena expands QC and analytical microbiology laboratories
By
LabPulse.com staff writers
Early drug development phase bioassay developer Abzena has expanded its microbiology laboratory facility in San Diego.
October 31, 2024
Caris Life Sciences embarks on 10K-sample breast cancer biomarker analysis project
By
LabPulse.com staff writers
Caris will perform comprehensive molecular characterization of TAILORx tissue samples.
October 25, 2024
New York State OKs NeoGenomics' pancancer solid tumor, targeted lung NGS tests
By
LabPulse.com staff writers
The New York State Department of Health has granted conditional approval for two NeoGenomics' next-generation sequencing (NGS) tests.
October 22, 2024
Dana-Farber researchers develop CRISPR-based tests for leukemia
By
LabPulse.com staff writers
Researchers at the Dana-Farber Cancer Institute have created CRISPR-based diagnostics for two types of gene fusion-driven leukemia.
October 10, 2024
Page 1 of 99
Next Page
